Association of High-Sensitivity C-Reactive Protein With Aneurysm Sac Shrinkage in Patients Undergoing Endovascular Abdominal Aneurysm Repair

Abstract

Purpose:

The factors associated with aneurysm sac shrinkage after endovascular aneurysm repair (EVAR) are not well established. As inflammation is implicated in aneurysm pathophysiology, we hypothesized that high-sensitivity C-reactive protein (hsCRP) was associated with aneurysm sac shrinkage after EVAR and compared the preoperative level of hsCRP between patients with and without postoperative aneurysm sac shrinkage after EVAR.

Methods:

From November 2013 to April 2019, 143 patients undergoing EVAR using Gore C3 Excluder (W. L. Gore & Associates, Inc, Flagstaff, Arizona) at our university hospital were included in this study. Aneurysm sac size was compared between that on baseline preoperative computed tomography (CT) and that on postoperative CT scans. A change in aneurysm sac size ≥5 mm was considered to be significant, whether due to enlargement or shrinkage.

Results:

Aneurysm sac size showed a significant decrease from 50.6 ± 9.8 mm to 47.1 ± 10.3 mm at 1 year. At 1 year postoperatively, aneurysm sac shrinkage (≥5 mm) was observed in 48 patients (34%), a stable aneurysm sac was noted in 93 patients (65%), and aneurysm sac enlargement was noted in 2 patients (1.4%). The mean preoperative hsCRP was 0.33 ± 0.54 mg/dL. Univariable analysis showed that preoperative hsCRP (p=0.029) and the presence of a renal cyst (p=0.002) were associated with aneurysm sac shrinkage. Multivariable analysis showed that preoperative hsCRP [>0.19mg/dL] (odds ratio [OR] = 0.22; 95% confidence interval [CI] = 0.05–0.96; p=0.042), and the presence of a renal cyst (OR = 0.31; 95% CI = 0.15–0.67; p=0.002) were independent risk factors for aneurysm sac shrinkage after EVAR.

Conclusions:

The level of preoperative hsCRP was independently associated with aneurysm sac shrinkage after EVAR in patients with abdominal aortic aneurysms. These data suggest that the high level of hsCRP can be a negative predictor for aneurysm sac shrinkage after EVAR.

Keywords

abdominal aortic aneurysm endovascular aneurysm repair high-sensitivity C-reactive protein inflammation shrinkage

Get full access to this article

View all access options for this article.

References

Lee

Carter

Upchurch

, et al. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg. 2004;39:491–496.

Greenhalgh

Brown

Kwong

GPS

, et al. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: a randomized controlled trial. Lancet. 2004;364:843–848.

Brewster

Jones

Chung

, et al. Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg. 2006;244:426–438.

Patel

Sweeting

Powell

, et al. Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomized controlled trial. Lancet. 2016;388:2366–2374.

Bastos Gonçalves

Baderkhan

Verhagen

, et al. Early sac shrinkage predicts a low risk of late complications after endovascular aortic aneurysm repair. Br J Surg. 2014;101:802–810.

Houbballah

Majewski

Becquemin

JP.

Significant sac retraction after endovascular aneurysm repair is a robust indicator of durable treatment success. J Vasc Surg. 2010;52:878–883.

Lalys

Daoudal

Gindre

, et al. Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg. 2017;65:1830–1838.

Liapis

Paraskevas

KI.

The pivotal role of matrix metalloproteinases in the development of human abdominal aortic aneurysms. Vasc Med. 2003;8:267–271.

Jagadesham

Scott

Carding

SR.

Abdominal aortic aneurysms: an autoimmune disease. Trends Mol Med. 2008;14:522–529.

10.

Quintana

Taylor

WR.

Cellular mechanisms of aortic aneurysm formation. Circ Res. 2019;124:607–618.

11.

Shalaby

Foster

Hall

, et al. Systemic inflammatory disease and its association with type II endoleak and late interventions after endovascular aneurysm repair. JAMA Surg. 2016;151:147–153.

12.

Vainas

Lubbers

Stassen

FRM

, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103–1105.

13.

Norman

Spencer

Lawrence-Brown

, et al. C-reactive protein levels and expansion of screen-detected abdominal aortic aneurysms in men. Circulation. 2004;110:862–866.

14.

Badger

Soong

O’Donnell

, et al. C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. J Vasc Surg. 2009;49:178–184.

15.

JCS Joint Working Group. Guidelines for diagnosis and treatment of aortic aneurysm and dissection (JCS 2011). Circ J. 2013;77:789–828.

16.

Lee

Choe

Kim

, et al. High-sensitivity C-reactive protein and cancer. J Epidemiol. 2011;21:161–168.

17.

Nishibe

Dardik

Koizumi

, et al. Simple renal cyst and its association with sac shrinkage after endovascular aneurysm repair for abdominal aortic aneurysm. J Vasc Surg. 2020;71:1890–1898.

18.

Dillavou

Buck

Muluk

, et al. Two-dimensional versus three-dimensional CT scan for aortic measurement. J Endovasc Ther. 2003;10:531–538.

19.

Marchiori

von Ristow

Guimaraes

, et al. Predictive factors for the development of type II endoleaks. J Endovasc Ther. 2011;18:299–305.

20.

Piazza

Squizzato

Miccoli

, et al. Definitive of type II endoleak risk based on preoperative anatomical characteristics. J Endovasc Ther. 2017;24(4):566–572.

21.

Whaley

Cassimjee

Novak

, et al. The spatial morphology of intraluminal thrombus influences type II endoleak after endovascular repair of abdominal aortic aneurysm. Ann Vasc Surg. 2020;66:77–84.

22.

Lederle

Wilson

Johnson

, et al. Variability in measurement of abdominal aortic aneurysms. Abdominal aortic aneurysm detection and management veterans administration cooperative study group. J Vasc Surg. 1995;21:945–952.

23.

Fujimura

Matsubara

Takahara

, et al. Early sac shrinkage is a good surrogate marker of durable success after endovascular aneurysm repair in Japanese patients. J Vasc Surg. 2018;67:1410–1418.

24.

O’Donnell

TFX

Deery

Boitano

, et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. 2019;69:414–422.

25.

Choke

Cockerill

Wilson

, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227–244.

26.

Ernst

CB.

Abdominal aortic aneurysm. N Engl J Med. 1993;328:1167–1172.

27.

Wills

Thompson

Crowther

, et al. Pathogenesis of abdominal aortic aneurysms-cellular and biochemical mechanisms. Eur J Vasc Endovasc Surg. 1996;12:391–400.

28.

Moutachakkir

Hanchi

Baraou

, et al. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann Biol Clin. 2017;75:225–229.

29.

Yousuf

Mohanty

Martin

, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408.

30.

Filis

Martinakis

Galyfos

, et al. Osteopontin and osteoprotegerin as potential biomarkers in abdominal aortic aneurysm before and after treatment. Int Sch Res Notices. 2014;2014:461239.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB